Showing 4,321 - 4,340 results of 16,260 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 5 ((ng decrease) OR (nn decrease)) ))', query time: 0.61s Refine Results
  1. 4321

    Basic characteristics included in the study. by Juan Gu (288925)

    Published 2025
    “…</p><p>Methods and analysis</p><p>We searched PubMed, Cochrane Library, Embase, and Web of Science for cohort studies published up to June 21, 2024, using relevant medical subject headings (MeSH) and keywords. …”
  2. 4322

    Publication bias of the risk of all groups. by Juan Gu (288925)

    Published 2025
    “…</p><p>Methods and analysis</p><p>We searched PubMed, Cochrane Library, Embase, and Web of Science for cohort studies published up to June 21, 2024, using relevant medical subject headings (MeSH) and keywords. …”
  3. 4323

    Study selection process. by Juan Gu (288925)

    Published 2025
    “…</p><p>Methods and analysis</p><p>We searched PubMed, Cochrane Library, Embase, and Web of Science for cohort studies published up to June 21, 2024, using relevant medical subject headings (MeSH) and keywords. …”
  4. 4324

    The process of selecting participants. by Na Li (6550)

    Published 2024
    “…The primary endpoint was considered as OS and CSS. We conducted trend analysis of the incidence, OS and CSS rates of liver metastases in ovarian cancer. …”
  5. 4325

    C-indexes for the nomograms. by Na Li (6550)

    Published 2024
    “…The primary endpoint was considered as OS and CSS. We conducted trend analysis of the incidence, OS and CSS rates of liver metastases in ovarian cancer. …”
  6. 4326
  7. 4327
  8. 4328
  9. 4329
  10. 4330
  11. 4331

    Experimental design. by Xueyan Lin (448667)

    Published 2025
    “…The C and MNS group were gavaged with equal volume normal saline, the ML and MR group gavaged with lactulose at a dose of 10 mL/kg body weight and rifaximin at a dose of 50 mg/kg body weight respectively once a day for 8 weeks until the end of the experiment. …”
  12. 4332
  13. 4333

    Patients outcome. by Loïc Duron (6433634)

    Published 2025
    “…Reliance on temporal-artery biopsy fell (17% vs 91%; p < 0.01), owing to a four-fold rise in diagnostic MRI use. Mean total medical costs decreased by €814 per patient (€3672 ± 2861 vs €4486 ± 3193), although this difference did not reach statistical significance (p = 0.23).…”
  14. 4334

    Primers for qPCR. by Kaitao Zhao (3617825)

    Published 2025
    “…Results revealed the MRE11–RAD50–NBS1 (MRN) complex as a potential factor. Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
  15. 4335

    Antibodies used for western blotting. by Kaitao Zhao (3617825)

    Published 2025
    “…Results revealed the MRE11–RAD50–NBS1 (MRN) complex as a potential factor. Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
  16. 4336

    Target sequences of siRNAs. by Kaitao Zhao (3617825)

    Published 2025
    “…Results revealed the MRE11–RAD50–NBS1 (MRN) complex as a potential factor. Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
  17. 4337

    Plasmids information. by Kaitao Zhao (3617825)

    Published 2025
    “…Results revealed the MRE11–RAD50–NBS1 (MRN) complex as a potential factor. Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
  18. 4338

    Raw data. by Kaitao Zhao (3617825)

    Published 2025
    “…Results revealed the MRE11–RAD50–NBS1 (MRN) complex as a potential factor. Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
  19. 4339
  20. 4340

    Baseline characteristics for pneumonia. by Mathias Aagaard Christensen (19139443)

    Published 2024
    “…For pneumonia, the ROC-AUCs were 50.1% [49.6%-50.6%], 69.2% [69.1%-69.2%] and 68.4% [68.0%-68.5%] for the linear models and 51.0% [49.7%-52.4%], 69.7% [.5%-70.8%] and 69.7% [68.6%-70.8%] for the deep learning SNP, clinical and combined models, respectively.…”